Patents
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
07/2006
07/13/2006US20060154951 Quaternary antimuscarinic compounds for the treatment of bladder diseases
07/12/2006EP1677796A2 Muscarinic acetylcholine receptor antagonists field of the invention
07/12/2006EP1677795A1 Muscarinic acetycholine receptor antagonists
07/11/2006CA2227984C Aza-anthracyclinone derivatives
07/06/2006US20060148847 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
07/06/2006US20060148840 Pyrrolodihydroisoquinolines as pde10 inhibitors
07/06/2006US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer
07/05/2006EP1675851A1 Method for producing n-substituted 3beta-aminonortropanes
07/05/2006EP1259241B1 The use of scopolamine salts
07/05/2006CN1798745A Novel 8-aza-bicyclo not 3.2.1|octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
07/04/2006US7071216 Anticancer agents
07/04/2006US7070800 Inhalable powder containing tiotropium
06/2006
06/29/2006WO2006069277A1 TRICYCLIC δ-OPIOID MODULATORS
06/29/2006WO2006069276A2 TRICYCLIC ō-OPIOID MODULATORS
06/29/2006WO2006069125A1 Indazole-carboxamide compounds
06/29/2006WO2006068904A1 Tetrahydroquinoline analogues as muscarinic agonists
06/29/2006WO2006067584A1 8-aza-bicyclo (3.2.1) octane derivatives with an activity on chemokine ccr5 receptors
06/29/2006WO2006052889A3 Quinolinone-carboxamide compounds
06/29/2006US20060142331 of serotonin, dopamine and noradrenaline receptors; e.g. 2-(2,3-Dichlorophenoxymethyl)-8-methyl-3-(3-chlorophenyl)-8-aza-bicyclo[3.2.1]octane; antidepressant. anxiolytic agent; eating, bipolar disorders, obesity; drug, tobacco, alcohol abuse; neurodegenerative diseases
06/29/2006CA2594602A1 8-aza-bicyclo (3.2.1) octane derivatives with an activity on chemokine ccr5 receptors
06/29/2006CA2592464A1 Tricyclic .delta.-opioid modulators
06/29/2006CA2591963A1 Tricyclic o-opioid modulators
06/29/2006CA2591766A1 Tetrahydroquinoline analogues as muscarinic agonists
06/29/2006CA2588037A1 Indazole-carboxamide compounds
06/28/2006EP1673089A2 Phenyl-piperazine derivatives as modulators of muscarinic receptors
06/28/2006EP1673083A2 N-substituted azacycles
06/27/2006CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators
06/22/2006WO2006064340A2 Process for the preparation of n-acyl beta-aminoaldehydes
06/22/2006US20060135764 Indazole-carboxamide compounds
06/22/2006US20060135504 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
06/22/2006DE102004061008A1 3-Arylalkyl- und 3-Heteroarylalkyl-substituierte 1,2,4-Triazin-5(2H)-one 3-arylalkyl and heteroarylalkyl 3-substituted-1,2,4-triazine-5 (2H) -ones
06/22/2006DE102004061006A1 3-Benzylthio-1,2,4-triazin-5(2H)-one 3-benzylthio-1,2,4-triazin-5 (2H) -ones
06/21/2006EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives
06/21/2006CN1791598A Benzimidazole-derivatives as factor Xa inhibitors
06/15/2006WO2005007134A8 Powdery formulations for inhalation, containing a novel anticholinergic agent
06/15/2006US20060128756 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
06/15/2006US20060128637 Phenolic acid complexes of hyoscyamine and process for preparing the same
06/13/2006USRE39128 Antibacteria drug; respiratory system disorders; otitis
06/13/2006US7060717 Phosphodiesterase inhibitor; antiinflammatory agents; antiallergens; respiratory system disorders; wound healing agents
06/13/2006CA2268954C Oxadiazoles, processes for their preparation and their use as medicaments
06/08/2006WO2006044174A3 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor
06/08/2006WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists
06/08/2006US20060122218 e.g. (2R,3S)-2-(2,3-Dichlorophenoxymethyl)-8-methyl-3-(2-thienyl-8-aza-bicyclo[3.2.1]octane; antidepressants; anxiolytic agents
06/08/2006US20060122171 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases
06/08/2006US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide
06/07/2006EP1664036A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
06/07/2006EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
06/07/2006EP1664017A1 Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors
06/07/2006EP1663220A1 Novel process, salts, compositions and use
06/07/2006EP1492789B1 Tropane derivatives as ccr5 modulators
06/07/2006CN1784393A Chemical compounds
06/01/2006WO2006056081A1 Method for preparing hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-one esters
06/01/2006US20060116393 Substituted pyrido [2,1-a] isoquinoline derivatives
05/2006
05/31/2006EP1420644B1 Substituted propargylamines
05/31/2006EP1163238B1 Chemokine recpetor binding heterocyclic compounds
05/31/2006CN1780833A Tropane derivatives and their use as ace inhibitors
05/30/2006US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA)
05/30/2006CA2321380C 6-azauracil derivatives as thyroid receptor ligands
05/23/2006US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/18/2006WO2006052640A1 5-ht4 receptor agonist compounds
05/18/2006WO2005067537A3 Muscarinic acetylcholine receptor antagonists
05/18/2006US20060106219 making a fluoro radioactive material [18F]Fluorohaloalkanes radiotracer through halogenation, or solid phase synthesis; use in positron emission tomography (PET) studies
05/17/2006EP1657239A2 Chromene compound
05/16/2006US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field
05/16/2006CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/11/2006WO2005099706A3 Muscarinic acetylcholine receptor antagonists
05/11/2006US20060100426 Containing a nortropane ring, e.g., 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[2-hydroxy-3-(4-methanesulfonylpiperazin-1-yl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; 5-HT4 receptor agonists
05/11/2006US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/10/2006EP1655294A2 Chromene compound
05/10/2006EP1655293A2 Chromene compound
05/09/2006US7041674 nortropane or nortropene derivatives; antagonists of the M3 receptor for treating asthma, COPD, vagally induced sinus bradycardia, arrhythmia, gastrointestinal and urinary tract spasms, and menstrual pain
05/09/2006US7041667 CCR5 modulators
05/09/2006CA2418908C 1,4-dihydropyridines as bradykinin antagonists
05/09/2006CA2395653C New inhalable powder containing tiotropium
05/03/2006EP1651230A1 Medicaments for inhalation comprising steroids and a novel anticholinergic
05/03/2006EP1651223A1 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts
05/03/2006EP0937069B1 Piperazino derivatives as neurokinin antagonists
05/03/2006CN1768051A Substituted pyrazoles
05/03/2006CN1767859A Improved radiometal complex compositions
04/2006
04/27/2006WO2006044174A2 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor
04/27/2006CA2581745A1 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor
04/26/2006EP1648888A1 N-(heterobicycloalkanes)-substituted indoles or heteroderivatives thereof
04/26/2006EP1648462A1 Muscarinic acetylcholine receptor antagonists
04/26/2006EP1648461A2 Muscarinic acetylcholine receptor antagonists
04/26/2006EP1648460A1 Muscarinic acetylcholine receptor antagonists
04/26/2006EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
04/26/2006CN1764661A Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain.
04/26/2006CN1764458A Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
04/20/2006WO2006021655A3 Oxopiperidine derivatives, preparation and therapeutic use thereof
04/20/2006WO2006018609A3 Anti-inflammatory agents
04/20/2006US20060083692 Combination of formoterol and a tiotropium salt
04/19/2006EP1646365A1 Powdery formulations for inhalation, containing a novel anticholinergic agent
04/19/2006CN1252068C Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1
04/18/2006US7030138 Benzamidine derivatives
04/13/2006WO2006038989A1 Substituted arylamides
04/13/2006US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors
04/12/2006EP1644398A1 Specific glucocorticosteroid compound having anti- inflammatory activity
04/12/2006EP1644397A1 Specific glucocorticosteroid compound having anti- inflammatory activity
04/12/2006EP1644343A1 5-substituted quinazolinone derivatives
04/12/2006EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 53